Incannex Healthcare (ASX: IHL) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Incannex Healthcare Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Incannex Healthcare (ASX: IHL)
Latest News
Share Gainers
Why Core Lithium, European Lithium, Incannex, and Qantas shares are pushing higher
Share Fallers
The Incannex share price has plunged 70% so far in 2022. What's gone so wrong?
Share Gainers
3 ASX All Ordinaries shares going great guns on Thursday
Cannabis Shares
Green shoots or just weeds? The outlook for ASX cannabis shares in FY23
Cannabis Shares
How did ASX cannabis shares perform in FY22?
Healthcare Shares
Here's how ASX 200 healthcare shares performed in June
Share Market News
5 worst ASX All Ordinaries shares in June
Cannabis Shares
Remember when ASX cannabis shares were smoking hot? Where are they now?
Healthcare Shares
Incannex share price pops 9% on FDA news
Share Gainers
Why CBA, Incannex, Judo Capital, and Orica shares are rising
Cannabis Shares
Here's why the Incannex share price is rocketing 18% today
Healthcare Shares
Down 25% in a month, the Incannex share price is now halted. Here's why
Frequently Asked Questions
-
Incannex listed on the ASX in May 2007.
-
No, Incannex has not yet paid out any dividends.
IHL ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Incannex Healthcare
Incannex Healthcare Ltd (ASX: IHL) is a developer of cannabinoid and psychedelic compound medicines. It is currently involved in clinical programs for the treatment of six conditions: Obstructive Sleep Apnea (OSA), Generalised Anxiety Disorder (GAD), traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions.
The company has an Australian license to import, export, and distribute medicinal cannabis products and has a line of cannabinoid products.